Working Group Scope The development and adoption of data standards over the last decade has shown significant promise in improving efficient delivery of data to support drug product and device submissions as well as the review process. However, there have also been gaps, issues and challenges in the interpretation and use of data standards. This Working Group will identify specific gaps that prevent FDA and industry from Optimizing the Use of Data Standards. This Working Group will collaborate to close those gaps. |
...